With the large collection of mutations, we have identified 8 hotspot residues in the MH2 domain, including some not reported before, and revealed that the proportions of hotspot and deleterious SMAD4 mutations differ substantially between cancers, with the fraction of hotspot mutations significantly enriched in READ (86%) and the lowest in PAAD (27%). Here, SMAD4 is linked to cancer.